Anhui Anke BioTech Group Net Asset Quality Index
Anhui Anke BioTech Group net asset quality index. Anhui Anke BioTech Group (300009) has a Net Asset Quality Index of 86.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.13 Billion minus total liabilities of CN¥714.45 Million yields net assets of CN¥4.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Anhui Anke BioTech Group for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Anhui Anke BioTech Group (2006–2025)
Net asset quality index of Anhui Anke BioTech Group from 2006 to 2025. This chart shows how Anhui Anke BioTech Group's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of June 2026, the index stands at 86.1%, representing net assets of CN¥4.41 Billion against total assets of CN¥5.13 Billion CNY. Check Anhui Anke BioTech Group strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Anhui Anke BioTech Group Net Asset Quality Index by Year (2006–2025)
Anhui Anke BioTech Group net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Anhui Anke BioTech Group from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Anhui Anke BioTech Group (300009) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.4% | CN¥4.74 Billion | CN¥5.55 Billion | CN¥811.30 Million | ▲ +1.6 pp |
| 2024 | 83.7% | CN¥4.30 Billion | CN¥5.14 Billion | CN¥835.41 Million | ▲ +4.3 pp |
| 2023 | 79.4% | CN¥3.93 Billion | CN¥4.95 Billion | CN¥1.02 Billion | ▼ -0.5 pp |
| 2022 | 79.9% | CN¥3.40 Billion | CN¥4.26 Billion | CN¥855.17 Million | ▲ +0.8 pp |
| 2021 | 79.1% | CN¥2.90 Billion | CN¥3.67 Billion | CN¥765.52 Million | ▼ -3.9 pp |
| 2020 | 83.0% | CN¥2.93 Billion | CN¥3.53 Billion | CN¥600.29 Million | ▼ -0.7 pp |
| 2019 | 83.7% | CN¥2.70 Billion | CN¥3.23 Billion | CN¥526.19 Million | ▲ +4.1 pp |
| 2018 | 79.6% | CN¥2.01 Billion | CN¥2.53 Billion | CN¥515.86 Million | ▲ +1.5 pp |
| 2017 | 78.1% | CN¥1.76 Billion | CN¥2.25 Billion | CN¥493.73 Million | ▲ +5.5 pp |
| 2016 | 72.6% | CN¥1.43 Billion | CN¥1.97 Billion | CN¥539.04 Million | ▼ -18.3 pp |
| 2015 | 90.9% | CN¥1.26 Billion | CN¥1.39 Billion | CN¥126.48 Million | ▲ +6.4 pp |
| 2014 | 84.5% | CN¥773.47 Million | CN¥915.58 Million | CN¥142.11 Million | ▼ -3.6 pp |
| 2013 | 88.1% | CN¥660.60 Million | CN¥749.81 Million | CN¥89.21 Million | ▼ -0.7 pp |
| 2012 | 88.8% | CN¥580.03 Million | CN¥652.93 Million | CN¥72.91 Million | ▼ -1.3 pp |
| 2011 | 90.1% | CN¥543.88 Million | CN¥603.65 Million | CN¥59.77 Million | ▲ +1.5 pp |
| 2010 | 88.6% | CN¥522.30 Million | CN¥589.55 Million | CN¥67.25 Million | ▼ -2.8 pp |
| 2009 | 91.3% | CN¥495.41 Million | CN¥542.36 Million | CN¥46.95 Million | ▲ +24.7 pp |
| 2008 | 66.7% | CN¥148.64 Million | CN¥222.96 Million | CN¥74.32 Million | ▲ +8.7 pp |
| 2007 | 58.0% | CN¥137.09 Million | CN¥236.55 Million | CN¥99.46 Million | ▲ +3.9 pp |
| 2006 | 54.0% | CN¥122.00 Million | CN¥225.72 Million | CN¥103.72 Million | — |